Preparation of oxime HI-6 (dichloride and dimethanesulphonate) - Antidote against nerve agents

Defence Science Journal

Volumn 58, Issue 3, 2008, Pages 399-404

  Kuca, Kamil ^a,b   Stodulka, Petr ^a,c   Hrabinova, Martina ^a   Hanusova, Petra ^c   Jun, Daniel ^a,b   Dolezal, Bohumil ^c  

^a Center of Advanced Studies   (Czech Republic)

^b Department of Toxicology ^*  (Czech Republic)

^c Vakos XT as   (Czech Republic)

Author keywords

Acetylcholinesterase; Antidote; HI 6; Nerve agent; Organophosphate; Oxime; Quaternary salts; Reactivator

Indexed keywords

MILITARY EQUIPMENT;

ACETYLCHOLINESTERASE; ANTIDOTE; HI-6; NERVE AGENTS; ORGANOPHOSPHATE; OXIME; QUATERNARY SALTS; REACTIVATOR;

CHEMICAL ENGINEERING;

EID: 44649192399     PISSN: 0011748X     EISSN: None     Source Type: Journal    
DOI: 10.14429/dsj.58.1660     Document Type: Article

References (29)

1. Petroianu, G.A.; Nurulain, S.M.; Nagelkerke, N.; Al-Sultan, M.A.H.; Kuca, K. & Kassa, J. Five oximes (K-27, K-33, K-48, BI-6, and methoxime) in comparison with pralidoxime: Survival in rats exposed to the organophosphate paraoxon. J. Appl. Toxicol., 2006, 26, 262-68.
2. Petroianu, G.A.; Arafat, K.; Kuca, K. & Kassa, J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime. In vitro reactivation of red blood cell acetylcholinesterase inhibitied by paraoxon. J. Appl. Toxicol., 2006, 26, 64-71.
3. Bajgar, J. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem., 2004, 38, 151-216.
4. Segura-Aguilara, J. & Kostrzewa, R.M. Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotoxicological Research, 2004, 6, 615-30.
5. Gupta, R.C. Toxicology of organophosphate and carbamate compounds, Ed. 2. Elsevier Academic Press, Burlington, California, London, 2006. 768p.
6. Ekstrom, F.; Akfur, C.; Tunemalm, A.K. & Lundberg, S. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry, 2006, 45, 74-81.
7. Patocka, J.; Kuca, K. & Jun, D. Acetylcholinesterase: Crucial enzyme of human body. Acta Medica, 2004, 47, 215-30.
8. Patocka, J.; Cabal, J.; Kuca, K. & Jun, D. Oxime reactivation of acetylcholinesterase inhibited by toxic phosphorus ester: In vitro kinetics and thermodynamics. J. Appl. Biomed., 2005, 3, 91-99.
9. Patocka, J.; Jun, D.; Bajgar, J. & Kuca, K. Prophylaxis against nerve agent intoxications. Def. Sci. J., 2006, 56, 775-84.
10. Racakova, V.; Jun, D.; Opletalova, V. & Kuca, K. Reactivation of acetycholinesterase inhibited by pesticide chlorpyrifos. J. Appl. Biomed., 2006, 4, 147-51.
11. Tu, A.T. Chemical terroriim: Horrors in Tokyo subway and Matsumoto city, Ed. 1. Alaken Inc., 2002. 240 p.
12. Musilek, K.; Kuca, K.; Jun, D.; Dohnal, V. & Dolezal, M. Synthesis of the novel series of bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J. Enzym. Inhib. Med. Chem., 2005, 20, 409-15.
13. Musilek, K.; Kuca, K.; Jun, D.; Dohnal, V. & Dolezal, M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett., 2006, 16, 622-27.
14. Musilek, K.; Kuca, K.; Jun, D. & Dolezal, M. Progress in synthesis of new acetylcholinesterase reactivators during the period 1990-2004. Curr. Org. Chem. 2007, 11, 229-38.
15. 2 linkers between pyridinium rings and their reactivity against VX. Bioorg. Med. Chem. Lett., 2006, 16, 4852-855.
16. Kim, T.H.; Kuca, K.; Jun, D. & Jung, Y.S. Design and synthesis of new bis-pyridinium oximes as cyclosarin-inhibited acetylcholinesterase reactivators. Bioorg. Med. Chem. Lett., 2005, 15, 2914-917.
17. Lundy, P.M.; Raveh, L. & Amitai, G. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicology Reviews, 2006, 25, 231-43.
18. Kuca, K.; Jun, D. & Musilek, K. Structural requirements of acetylcholinesterase reactivators. Mini-Rev. Med. Chem., 2006, 6, 269-77.
19. Yang, G.Y.; Yoon, J.H.; Seong, C.M.; Park, N.S. & Jung, Y.S. Synthesis of Bis-pyridinium oxime antidotes using bis(methylsulfonoxymethyl) ether for organophosphate nerve agents. Bull. Kor. Chem. Soc., 2003, 24, 1368-370
20. Hagedorn I. Bis-quaternary pyridinium-2-aldoxime salts and a process for their preparation. USA Patent 4, 128, 651. 5 December 1978. 6 p.
21. Hagedorn, I. Bisquaternary pyridinium salts. US Patent 3, 773, 775. 20 November 1973. 4 p.
22. Kuca, K.; Bielavsky, J.; Cabal, J. & Bielavska, M. Synthesis of a potential reactivator of acetylcholinesterase 1 -(4-hydroxyiminomethyl pyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Letters, 2003, 44, 3123-125.
23. Kuca, K.; Bielavsky, J.; Cabal, J. & Kassa, J. Synthesis of a new reactivator of tabun inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett., 2003, 13, 3545-547.
24. Kuca, K.; Cabal, J.; Patocka, J. & Kassa, J. Synthesis of bisquaternary symmetric - chi.delta-bis(2-hydroxyiminomethylpyridinium)alkane dibromides and their reactivation of cyclosarininhibited acetylcholinesterase. Lett. Org. Chem., 2004, 1, 84-86.
25. Jun, D.; Stodulka, P.; Kuca, K.; Koleckar, V.; Dolezal, B.; Simon, P. & Veverka, M. HPLC analysis of HI-6 dichloride and dimethanesulfonateantidotes against nerve agents and organophosphorus pesticides. Analytical Letter, 2007.
26. Jun, D.; Stodulka, P.; Kuca, K.; Koleckar, V.; Dolezal, B.; Simon, P.; Veverka, M. TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate. J. Chrom. Sci., 2007.
27. Cabal, J.; Kuca, K. & Kassa, J. Specification of the structure of oximes able to reactivate tabun inhibited acetylcholinesterase. Bas. Clin. Pharm. Tox., 2004, 95, 81-86.
28. Kassa, J.; Kuca, K.; Bartosova, L. & Kunesova, G. The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr. Org. Chem., 2007, 11, 267-83.
29. Monov, A. & Dishovsky, C. Medical aspects of chemical and biological terrorism chemical terrorism and traumatism, Ed. 1. Publishing House of the Union of Scientists in Bulgaria, Sofia, 2005. 354 p.